Pentoxifylline for ulcerative colitis
Treatments studied
Part of Digestive system clinical trials.
This trial tests if the drug pentoxifylline can help people with mild to moderate ulcerative colitis. It may offer a new treatment option for those not on other strong medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have mild or moderate ulcerative colitis
- You are not currently taking steroids, immunosuppressants, or biological therapies
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You do not have diabetes, colorectal cancer, serious liver or kidney problems
- You do not have a known allergy to pentoxifylline
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a medication called nitazoxanide can help people with mild to moderate ulcerative colitis (UC). It may be a treatment option for those not already on strong UC medications.
This study tests adding a medicine called mebendazole (normally used for parasites) to standard mesalamine treatment for people with mild or moderate ulcerative colitis. The goal is to see if it helps control inflammation better than mesalamine alone.
This study tests whether adding palmitoylethanolamide (a natural compound that may help reduce inflammation) to standard treatment can improve symptoms for people with active mild-to-moderate ulcerative colitis who are not responding well to current medications.
This trial tests whether adding febuxostat, a medicine usually used for gout, can help reduce inflammation in people with mild to moderate ulcerative colitis who are already taking mesalamine. It aims to see if this combination is safe and effective.
This trial tests a new oral medication for people with active ulcerative colitis that hasn't responded well to standard treatments. The goal is to see if the drug reduces inflammation and improves symptoms.
This trial tests an oral study drug called Hemay005 for people with moderate to severe ulcerative colitis (UC) who have not responded well to other treatments. If you join, you will receive either the study drug or a placebo (inactive pill) to see if it helps reduce symptoms and heal the gut lining.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.